SAM
VERA icon

Smartleaf Asset Management’s Vera Therapeutics VERA Stock Holding History

Smartleaf Asset Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.18K Hold
120
– – ﹤0.01% 2667
2026
Q1 		$4.57K Buy
120
+17
+17% +$732 ﹤0.01% 2699
2025
Q4 		$5.27K Buy
103
+92
+836% +$3.27K ﹤0.01% 2679
2025
Q3 		$317 Buy
11
+8
+267% +$185 ﹤0.01% 2914
2025
Q2 		$67 Buy
+3
New +$67 ﹤0.01% 2699
2025
Q1 		– Sell
-15
Closed -$630 – 3011
2024
Q4 		$630 Buy
15
+6
+67% +$266 ﹤0.01% 2746
2024
Q3 		$390 Sell
9
-4
-31% -$152 ﹤0.01% 2817
2024
Q2 		$450 Buy
+13
New +$516 ﹤0.01% 2565

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Smartleaf Asset Management's VERA Position: Q2 2026 in Review

Smartleaf Asset Management held its Vera Therapeutics (VERA) position steady in Q2 2026 at 120 shares worth $5.18K. The position accounts for ﹤0.01% of the portfolio, ranked #2667.

Smartleaf Asset Management first reported a position in VERA in Q2 2024 and has held it in 8 quarters since. The position peaked at $5.27K in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Smartleaf Asset Management held 120 shares of Vera Therapeutics worth $5.18K as of Q2 2026.
  • Smartleaf Asset Management left its Vera Therapeutics share count unchanged in Q2 2026.
  • Vera Therapeutics made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2667 holding.
  • Smartleaf Asset Management first reported a position in Vera Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Smartleaf Asset Management's Vera Therapeutics position peaked at $5.27K in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.